Effect of bortezomib, cyclophosphamide, and filgrastim on complete remission rates and CD34+ stem cell collections in multiple myeloma (MM)
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. Niesvizky, J. Stern, M. Manco, T. Mark, M. W. Schuster, T. B. Shore, J. G. Harpel, R. N. Pearse, F. Zafar, M. Coleman
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2240376638